Low Diagnostic Yield With Cystoscopy and CT Urography for Urinary Tract Cancers Low Diagnostic Yield With Cystoscopy and CT Urography for Urinary Tract Cancers

Few patients with microhematuria who undergo evaluation for urinary tract cancers with cystoscopy or CT urography are diagnosed with a malignancy, a systematic review and meta-analysis suggests.Reuters Health Information
Source: Medscape Radiology Headlines - Category: Radiology Tags: Hematology-Oncology News Source Type: news

Related Links:

CONCLUSION: HIVEC resulted in a 2-year HG-RFS of 35% for BCG-unresponsive NMIBC patients without severe side-effects and therefore HIVEC seems to be an alternative treatment option for patients who refuse or are unfit for RC.PMID:34470725 | DOI:10.1016/j.urolonc.2021.07.019
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Source Type: research
ConclusionsPreoperative examination with the latest available ureteroscopic technology can help preserve renal function in the case of benign tumors by enabling preoperative ureteroscopic biopsy or intraoperative rapid resection. Moreover, nephroureterectomy is recommended in the case of preoperative suspicion of ureteral malignant tumors.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
CONCLUSION: Blue-light flexible cystoscopy at the outpatient clinic may be a useful tool to solve unclear cases of a malignant or suspicious urinary cytology suggestive of bladder cancer. The procedure was well tolerated by the patients.PMID:34037496 | DOI:10.1080/21681805.2021.1928746
Source: Scandinavian Journal of Urology - Category: Urology & Nephrology Authors: Source Type: research
ConclusionXpert BC Monitor performance was superior to that of cytology in the follow-up of NMIBC. The exclusion of aggressive tumours with a very high NPV (99.7%) supports the use of this urinary test in daily practice.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research
Conclusion: Bladder cancer is a complex disease, and its management is evolving. Advances in therapy, understanding of the disease, and advanced imaging have ushered in a period of rapid change in the care of bladder cancer patients.
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research
Purpose of review The purpose of this review is to summarize the problem of asymptomatic microscopic hematuria (AMH) in women and the most recent publications on the topic. Recent findings Urologic malignancy is rarely associated with AMH in low-risk women. Screening for urologic malignancy includes upper urinary tract imaging and cystoscopy. Renal ultrasound is a cost-effective first-line imaging modality in patients with AMH. Multiphasic computed tomography (CT) urography increases healthcare costs, the risk of secondary malignancy due to cumulative radiation exposure, and the discovery of incidental benign findings...
Source: Current Opinion in Obstetrics and Gynecology - Category: OBGYN Tags: UROGYNECOLOGY: Edited by Kavita Mishra Source Type: research
Abstract Tumor follow-up in patients with non-muscle invasive bladder cancer (NMIBC) is a weighing up between the morbidity associated with invasive diagnostics and the risk of tumor recurrence and especially progression. The risk stratification into low, intermediate, and high-risk tumors enables a risk-adapted follow-up. For individual estimation of the risk of progression and recurrence, risk calculators should be used. Follow-up is still based on cystoscopy, which is recommended lifelong for high and intermediate-risk tumors and for up to 5 tumor-free years for low-risk tumors. Urine cytology has a&n...
Source: Der Urologe. Ausg. A - Category: Urology & Nephrology Authors: Tags: Urologe A Source Type: research
ConclusionFor initial diagnosis of BCa, cystoscopy is generally performed. However, cystoscopy cannot accurately detect carcinoma in situ and cannot distinguish benign masses from malignant lesions. CT is used in two modes, CT and computed tomographic urography, both for diagnosis and for staging of BCa. However, they cannot differentiate T1 and T2 BCa. MRI is performed to diagnose invasive BCa and can differentiate muscle invasive bladder carcinoma from non-muscle invasive bladder carcinoma. However, CT and MRI have low sensitivity for nodal staging. For nodal staging, PET/CT is preferred. PET/MRI provides a better differ...
Source: Clinical and Translational Imaging - Category: Radiology Source Type: research
An 83-year-old man was diagnosed with multiple low-grade transitional cell carcinomas over a 6-year period. A surveillance cystoscopy in year 7 showed high-grade noninvasive papillary urothelial carcinoma in the bladder trigone. A CT urogram showed a soft-tissue mass with diffuse enhancement in the lower pole of the left kidney, concerning for malignancy.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Tags: Bladder Cancer Genitourinary Cancers Oncology Journal Source Type: news
ConclusionCT urography is an accurate test for diagnosing bladder cancer; however, in protocols relying predominantly on excretory phase images, overall sensitivity remains insufficient to obviate cystoscopy. Awareness of bladder cancer mimics may reduce false-positive results. Improvements in CTU technique may reduce false-negative results.
Source: Abdominal Imaging - Category: Radiology Source Type: research
More News: Cancer | Cancer & Oncology | Cystoscopy | Hematology | Radiology | Urography